These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2255799)
1. Natural and corticosteroid-induced osteoporosis in sarcoidosis: prevention, treatment, follow up and reversibility. Rizzato G; Fraioli P Sarcoidosis; 1990 Sep; 7(2):89-92. PubMed ID: 2255799 [No Abstract] [Full Text] [Related]
2. Prevention of corticosteroid-induced osteoporosis with salmon calcitonin in sarcoid patients. Montemurro L; Schiraldi G; Fraioli P; Tosi G; Riboldi A; Rizzato G Calcif Tissue Int; 1991 Aug; 49(2):71-6. PubMed ID: 1913297 [TBL] [Abstract][Full Text] [Related]
3. Bone protection with salmon calcitonin (sCT) in the long-term steroid therapy of chronic sarcoidosis. Rizzato G; Tosi G; Schiraldi G; Montemurro L; Zanni D; Sisti S Sarcoidosis; 1988 Sep; 5(2):99-103. PubMed ID: 3227195 [TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-induced osteoporosis. Sambrook P Aust Fam Physician; 1994 Oct; 23(10):1965-6. PubMed ID: 7818398 [No Abstract] [Full Text] [Related]
5. Prevention and treatment of osteoporosis in patients with inflammatory bowel disease. Valentine JF; Sninsky CA Am J Gastroenterol; 1999 Apr; 94(4):878-83. PubMed ID: 10201450 [TBL] [Abstract][Full Text] [Related]
6. Letter: Calcitonin in steroid-induced osteoporosis. Palmieri GM; Dvorak J; Bottomley R N Engl J Med; 1974 Jun; 290(26):1490-1. PubMed ID: 4831772 [No Abstract] [Full Text] [Related]
7. [Corticosteroid-induced osteoporosis-- prevention and treatment]. Elkayam O; Paran D; Yaron M; Caspi D Harefuah; 1999 Mar; 136(6):489-92. PubMed ID: 10914270 [No Abstract] [Full Text] [Related]
8. Reversibility of exogenous corticosteroid-induced bone loss. Rizzato G; Montemurro L Eur Respir J; 1993 Jan; 6(1):116-9. PubMed ID: 8425581 [TBL] [Abstract][Full Text] [Related]
9. Tardive results of antiinflammatory treatment in sarcoidosis. Barbu Z; Barbu E; Alexa M; Jozefovics F Rev Med Chir Soc Med Nat Iasi; 1975; 79(4):633-4. PubMed ID: 178039 [No Abstract] [Full Text] [Related]
10. Bone loss in prednisone treated sarcoidosis: a two-year follow-up. Montemurro L; Fraioli P; Riboldi A; Delpiano S; Zanni D; Rizzato G Ann Ital Med Int; 1990; 5(3 Pt 1):164-8. PubMed ID: 2288818 [TBL] [Abstract][Full Text] [Related]
11. Researching, monitoring and treating osteoporosis in a Sarcoid Clinic: seven years of experience and follow-up. Rizzato G; Montemurro L; Fraioli P Sarcoidosis; 1991 Sep; 8(2):179-80. PubMed ID: 1669991 [No Abstract] [Full Text] [Related]
12. Deflazacort in pediatric rheumatic diseases needs a frequent follow-up of bone densitometry. Falcini F; Trapani S; Ermini M; Bartolozzi G Pediatrics; 1995 Feb; 95(2):318. PubMed ID: 7838659 [No Abstract] [Full Text] [Related]
13. Nocardiosis presenting as an anterior mediastinal mass in a patient with sarcoidosis. Jastrzembski SA; Teirstein AS; Herman SD; DePalo LR; Lento PA Mt Sinai J Med; 2002 Oct; 69(5):350-3. PubMed ID: 12415330 [TBL] [Abstract][Full Text] [Related]
14. [Systemic prolonged corticotherapy: prevention and treatment strategy for corticosteroid-induced osteoporosis]. Orcel P Rev Mal Respir; 1999 Jan; 16 Suppl 3():S96-7. PubMed ID: 10088267 [No Abstract] [Full Text] [Related]
15. Fractures in adults on systemic steroid therapy: which prophylaxis? Prescrire Int; 1999 Oct; 8(43):153-6. PubMed ID: 11503842 [TBL] [Abstract][Full Text] [Related]
16. Prednisone-induced bone loss in sarcoidosis: a risk especially frequent in postmenopausal women. Rizzato G; Tosi G; Mella C; Montemurro L; Zanni D; Sisti S Sarcoidosis; 1988 Sep; 5(2):93-8. PubMed ID: 3227194 [TBL] [Abstract][Full Text] [Related]
17. A ten-year study of corticosteroid treatment of pulmonary sarcoidosis. Johns CJ; Zachary JB; Ball WC Johns Hopkins Med J; 1974 May; 134(5):271-83. PubMed ID: 4826124 [No Abstract] [Full Text] [Related]
18. [Subcutaneous nodules as the initial manifestation of systemic sarcoidosis: response to treatment with oral corticoids]. Navarro Moreno L; Maldonado Pardo R; Gispert de Nicolau F; Camacho Cuartero L; Armario García P An Med Interna; 1996 Jun; 13(6):308-9. PubMed ID: 8962971 [No Abstract] [Full Text] [Related]
20. [Glucocorticoids and risk of osteoporosis. On the problem of equivalent dose of desirable and undesirable effects of various glucocorticoids, exemplified by deflazacort]. Rotenberger J; Köbberling J Med Klin (Munich); 1993 Jul; 88(7):432-7. PubMed ID: 8377721 [No Abstract] [Full Text] [Related] [Next] [New Search]